These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 29976492)

  • 1. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
    Tsang RW; Campbell BA; Goda JS; Kelsey CR; Kirova YM; Parikh RR; Ng AK; Ricardi U; Suh CO; Mauch PM; Specht L; Yahalom J
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):794-808. PubMed ID: 29976492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solitary plasmacytoma of bone and soft tissues.
    Tong D; Griffin TW; Laramore GE; Kurtz JM; Russell AH; Groudine MT; Herron T; Blasko JC; Tesh DW
    Radiology; 1980 Apr; 135(1):195-8. PubMed ID: 7360960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary plasmacytoma of bone vs. extramedullary plasmacytoma and their relationship to multiple myeloma.
    Corwin J; Lindberg RD
    Cancer; 1979 Mar; 43(3):1007-13. PubMed ID: 106950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solitary plasmacytoma.
    Dagan R; Morris CG; Kirwan J; Mendenhall WM
    Am J Clin Oncol; 2009 Dec; 32(6):612-7. PubMed ID: 19593082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solitary plasmacytoma of bone and soft tissue.
    Bolek TW; Marcus RB; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):329-33. PubMed ID: 8892456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
    Dimopoulos MA; Moulopoulos A; Delasalle K; Alexanian R
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):359-69. PubMed ID: 1582978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience.
    Alghisi A; Borghetti P; Maddalo M; Roccaro AM; Tucci A; Mazzola R; Magrini SM; Lo Casto A; Bonù ML; Tomasini D; Pasinetti N; Peretto G; Bertagna F; Tomasi C; Buglione M; Triggiani L
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1773-1779. PubMed ID: 33201300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of radiation therapy in the management of plasma cell tumors.
    Mill WB; Griffith R
    Cancer; 1980 Feb; 45(4):647-52. PubMed ID: 6153562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
    Dimopoulos MA; Moulopoulos LA; Maniatis A; Alexanian R
    Blood; 2000 Sep; 96(6):2037-44. PubMed ID: 10979944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoma. Treatment results and conversion to myeloma.
    Holland J; Trenkner DA; Wasserman TH; Fineberg B
    Cancer; 1992 Mar; 69(6):1513-7. PubMed ID: 1540888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.
    Shin HJ; Kim K; Lee JW; Song MK; Lee JJ; Lee HS; Lee WS; Kim SJ; Chung JS
    Eur J Haematol; 2014 Nov; 93(5):414-21. PubMed ID: 24813053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy in the management of solitary extramedullary plasmacytoma.
    Chao MW; Gibbs P; Wirth A; Quong G; Guiney MJ; Liew KH
    Intern Med J; 2005 Apr; 35(4):211-5. PubMed ID: 15836498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of plasmacytomas.
    Wasserman TH
    Oncology (Williston Park); 1987 Apr; 1(2):37-41. PubMed ID: 3275340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome.
    Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Stewart AK
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):113-20. PubMed ID: 11316553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma.
    Soutar R; Lucraft H; Jackson G; Reece A; Bird J; Low E; Samson D; ; ;
    Br J Haematol; 2004 Mar; 124(6):717-26. PubMed ID: 15009059
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
    Wilder RB; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
    Cancer; 2002 Mar; 94(5):1532-7. PubMed ID: 11920511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solitary plasmacytoma: experiences from Central Anatolia.
    Coskun HS; Er O; Soyuer S; Altinbas M; Eser B; Karahacioglu E; Altuntas F
    Ir J Med Sci; 2005; 174(1):33-6. PubMed ID: 15868887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rare intracranial plasmacytoma manifestations. Case reports and review of the literature in diffuse plasmocytoma, in primary solitary extramedullary plasmacytoma in in primary solitary osseous plasmacytoma].
    Kujat C; Reiche W; Koch B; Moringlane JR
    Radiologe; 1996 Nov; 36(11):914-20. PubMed ID: 9036433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma.
    Kim PJ; Hicks RJ; Wirth A; Ryan G; Seymour JF; Prince HM; Mac Manus MP
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):740-6. PubMed ID: 19038505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course of solitary extramedullary plasmacytoma.
    Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
    Radiother Oncol; 1999 Sep; 52(3):245-9. PubMed ID: 10580871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.